Modeling the transmission dynamics and control of hepatitis B virus in China.

Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV) and is a major global health problem. HBV is the most common serious viral infection and a leading cause of death in mainland China. Around 130 million people in China are carriers of HBV, almost a third of the people infected with HBV worldwide and about 10% of the general population in the country; among them 30 million are chronically infected. Every year, 300,000 people die from HBV-related diseases in China, accounting for 40-50% of HBV-related deaths worldwide. Despite an effective vaccination program for newborn babies since the 1990s, which has reduced chronic HBV infection in children, the incidence of hepatitis B is still increasing in China. We propose a mathematical model to understand the transmission dynamics and prevalence of HBV infection in China. Based on the data reported by the Ministry of Health of China, the model provides an approximate estimate of the basic reproduction number R(0)=2.406. This indicates that hepatitis B is endemic in China and is approaching its equilibrium with the current immunization program and control measures. Although China made a great progress in increasing coverage among infants with hepatitis B vaccine, it has a long and hard battle to fight in order to significantly reduce the incidence and eventually eradicate the virus.

[1]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[2]  D. Lavanchy,et al.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures , 2004, Journal of viral hepatitis.

[3]  A. Prasad,et al.  Letter: Zinc deficiency in man. , 1974 .

[4]  S. Locarnini Molecular virology of hepatitis B virus. , 2004, Seminars in liver disease.

[5]  A. McLean,et al.  Modelling the impact of mass vaccination against hepatitis B. I. Model formulation and parameter estimation , 1994, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[6]  J. Watmough,et al.  Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. , 2002, Mathematical biosciences.

[7]  J. Hou,et al.  Epidemiology and Prevention of Hepatitis B Virus Infection , 2005, International journal of medical sciences.

[8]  S. Hadler,et al.  Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. , 1989, Reviews of infectious diseases.

[9]  D J Nokes,et al.  The transmission dynamics and control of hepatitis B virus in The Gambia. , 1996, Statistics in medicine.

[10]  Jianhua Lu,et al.  Prevention and control of hepatitis B in China , 2002, Journal of medical virology.

[11]  Fangjun Zhou,et al.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact. , 2005, International journal of epidemiology.

[12]  D J Nokes,et al.  The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes , 1996, Epidemiology and Infection.

[13]  Colin W Shepard,et al.  Hepatitis B virus infection: epidemiology and vaccination. , 2006, Epidemiologic reviews.

[14]  O. Diekmann,et al.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations , 1990, Journal of mathematical biology.

[15]  Van Saene Hk,et al.  The prevention of ventilator-associated pneumonia. , 1999 .

[16]  A J Hall,et al.  The influence of age on the development of the hepatitis B carrier state , 1993, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[17]  K. Hyams Risks of chronicity following acute hepatitis B virus infection: a review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Roger Williams Global challenges in liver disease , 2006, Hepatology.

[19]  W. Edmunds,et al.  Vaccination against hepatitis B virus in highly endemic areas: waning vaccine-induced immunity and the need for booster doses. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  Z Xu,et al.  A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china. , 2000, International journal of epidemiology.

[21]  C. Bullen,et al.  Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy. , 2008, Journal of theoretical biology.

[22]  H. Zhuang,et al.  [The overview of the seminar on chronic hepatitis B]. , 2004, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[23]  O. Cj Prevention of primary liver cancer. , 1984 .

[24]  W. Edmunds,et al.  Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr , 1996, Epidemiology and Infection.

[25]  Graham F. Medley,et al.  Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control , 2001, Nature Medicine.

[26]  S. Tsung-Tang,et al.  A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine , 1986, Journal of cellular physiology. Supplement.

[27]  W. Edmunds,et al.  Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[28]  刘耕陶,et al.  对我国慢性病毒性肝炎防治与研究工作的建议 , 2002 .